These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Screening for vascular risk factors in glaucoma: the GVRF study. Zeyen T; Bull Soc Belge Ophtalmol; 2005; (298):53-60. PubMed ID: 16422222 [TBL] [Abstract][Full Text] [Related]
8. Variability in glaucomatous visual fields: implications for shared care schemes. Henson DB; Spry PG; Spencer IC; Sparrow JM Ophthalmic Physiol Opt; 1998 Mar; 18(2):120-5. PubMed ID: 9692031 [TBL] [Abstract][Full Text] [Related]
9. Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time. Janz NK; Wren PA; Guire KE; Musch DC; Gillespie BW; Lichter PR; Ophthalmology; 2007 Dec; 114(12):2213-20. PubMed ID: 17490746 [TBL] [Abstract][Full Text] [Related]
10. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Avisar R; Friling R; Snir M; Avisar I; Weinberger D Isr Med Assoc J; 2006 Dec; 8(12):880-1. PubMed ID: 17214111 [TBL] [Abstract][Full Text] [Related]
11. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL; Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of glaucoma in the wroclaw population. The wroclaw epidemiological study. Nizankowska MH; Kaczmarek R Ophthalmic Epidemiol; 2005 Dec; 12(6):363-71. PubMed ID: 16283988 [TBL] [Abstract][Full Text] [Related]
13. [Glaucoma in practices of ophthalmologists]. Heuer J; Kerek-Bodden H; Bertram B; Graubner B; Brenner G Gesundheitswesen; 2003 Nov; 65(11):648-52. PubMed ID: 14639523 [TBL] [Abstract][Full Text] [Related]
15. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Eid TM; Spaeth GL; Bitterman A; Steinmann WC Ophthalmology; 2003 May; 110(5):900-7. PubMed ID: 12750087 [TBL] [Abstract][Full Text] [Related]
16. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients. Horn FK; Wakili N; Jünemann AM; Korth M Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460 [TBL] [Abstract][Full Text] [Related]
17. Visual field progression in glaucoma: total versus pattern deviation analyses. Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955 [TBL] [Abstract][Full Text] [Related]
18. Estimation of blindness in India from 2000 through 2020: implications for the blindness control policy. Dandona L; Dandona R; John RK Natl Med J India; 2001; 14(6):327-34. PubMed ID: 11804362 [TBL] [Abstract][Full Text] [Related]
19. Oman Eye Study 2005: prevalence and determinants of glaucoma. Khandekar R; Jaffer MA; Al Raisi A; Zutshi R; Mahabaleshwar M; Shah R; Choudhury AH East Mediterr Health J; 2008; 14(6):1349-59. PubMed ID: 19161110 [TBL] [Abstract][Full Text] [Related]
20. Long-term survival of central visual field in end-stage glaucoma. Much JW; Liu C; Piltz-Seymour JR Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]